Authors
Latest:
Exposing Benefits and Barriers: mHealth Use in Managing HemophiliaDespite medical recommendations, many patients do not consistently remain adherent to their prophylactic schedule.
Latest:
Pharmacists Address Proper Dosing of Anticoagulants in CAD and PADIn a Pharmacy Times® Insights series, 2 experts agree that communication is incredibly valuable when discussing guidelines and recommendations.
Latest:
Pre-Chemo Enzalutamide Approved for Metastatic Castration-Resistant Prostate CancerThe FDA has expanded the approval for enzalutamide (Xtandi) to include the treatment of men with chemotherapy-naive metastatic castration-resistant prostate cancer.
Latest:
Value-Based Design and Prescription Drug Utilization Patterns Among Diabetes PatientsChanges in antidiabetic medication cost sharing due to a value-based pharmacy access program led to increased use of generic and brand antidiabetic oral medications and insulin.
Latest:
Health-Systems Pharmacists: Part of a Multidisciplinary TeamWorking as a health systems pharmacist is a well-rounded career and offers job fulfillment, satisfaction, and great earning potential.
Latest:
A Computerized Asthma Outcomes Measure Is Feasible for Disease ManagementThe ASTHMA-CAT, an online, patient-based assessment measure, may facilitate asthma care management.
Latest:
Caterpillar Breaks New Ground Managing the Prescription Drug Supply ChainBy eliminating waste in the prescription drug supply chain, Caterpillar lowered total drug costs while copayment tiers remained unchanged.
Latest:
Perserverance After Match Day Uncertainty Leads to OpportunityMatch day can be one of the most uplifting, validating, and encouraging of days.
Latest:
NASP 2019: A Doctor's Perspective on Specialty PharmacyThe annual National Association of Specialty Pharmacy annual meeting shed light on the significant role these caregivers play in patient care.
Latest:
Phase 3 Data Favor Bimekizumab Over Placebo in Biologic-Naïve Patients With Psoriatic ArthritisAll primary and ranked secondary endpoints of the study were met at week 16, which were sustained or improved through week 24 and were coupled with patient-reported improvements compared with placebo in treating psoriatic arthritis.
Latest:
ADA's New CEO Takes Over in Time for 78th Scientific SessionsTracey D. Brown will welcome 16,000 attendees to the premier diabetes health care conference in her first month as chief executive of the American Diabetes Association.
Latest:
Opportunistic Infections: Better Have a Pharmacist OnboardApproximately 1.2 million individuals live with HIV/AIDS in the United States. This population is at an increased risk of opportunistic infections (OIs), an area where pharmacists have significant potential to make meaningful interventions.
Latest:
Etanercept and Ustekinumab Dosing for Psoriasis and Psoriatic ArthritisFor patients with psoriasis and/or psoriatic arthritis, actual-to-expected dosing ratios and costs were lower for etanercept than for ustekinumab.
Latest:
Lasmiditan For the Acute Treatment of Migraine: An Opportunity For PharmacistsDespite triptan availability as a migraine-specific rescue, the global burden of migraine morbidity remains high.
Latest:
Sav-Mor Pharmacy: Marketing From the Inside OutThe Illinois pharmacy chain has attained success as a result of good planning and successful marketing strategies.
Latest:
Association Between Sustained Glycated Hemoglobin Control and Healthcare CostsTotal cost of care for patients whose glycated hemoglobin levels were
Latest:
Review of Outcomes Associated With Formulary Restrictions: Focus on Step TherapyAs healthcare spending continues to rise, more employers, managed care organizations, and pharmacy benefit managers are implementing novel pharmacy benefit designs and formulary management policies to control drug spending.
Latest:
Cancer Screening: Let's Talk About ItOver the past 2 decades, the cancer death rate has drastically declined in the United States, falling 23% from its 1991 peak. This translates to 1.7 million lives saved.
Latest:
FDA Approves Mepolizumab for Adults With Chronic Rhinosinusitis With Nasal PolypsThe FDA has approved the monoclonal antibody mepolizumab as a treatment for patients with chronic rhinosinusitis with nasal polyps.
Latest:
A New Monoclonal Antibody for R/R MM: Isatuximab-irfcIsatuximab-ifrc is the third monoclonal antibody approved for the treatment of R/R MM.
Latest:
A Look Into 2011 Drug Utilization Trend and BeyondSignificant factors for 2011 prescription utilization include the recession, change in employment rate, new generic and brand launches, and changes in Baby Boomers' retirement plans.
Latest:
Managed Care Biologics and InjectablesPayer response to new entrants to the multiple sclerosis (MS) market is mixed as some believe that there remain meaningful, major unmet needs in the MS category, according to The Zitter Group's Spring 2011 Managed Care Biologics and Injectables Index.
Latest:
Digital Technology: An Effective Communication Tool for Pharmacy Staff During COVID-19The COVID-19 pandemic made a convincing argument to employers of having a robust and sound communication strategy to their employees.
Latest:
Sodium-Glucose Cotransporter-2 Inhibitors for Treating Type 2 DiabetesDiabetes is a complex disease affecting 29.1 million individuals in the United States.
